Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06043271 · ClinicalTrials.gov registry record · NA

A Single Session Parenting Intervention for Children on a Outpatient Therapy Waitlist

A NA study of Anxiety Disorders, sponsored by Massachusetts General Hospital.

Recruiting
Registry status
NA
Development phase
54
Enrollment target
1
Study location

NCT06043271: Recruiting NA study of Anxiety Disorders, sponsored by Massachusetts General Hospital.

NCT06043271 is a NA study of Anxiety Disorders that is actively recruiting participants, run by Massachusetts General Hospital. The registered enrollment target is 54 participants, below the 1,139-participant average among 84 other Anxiety Disorders trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06043271, a NA study of Anxiety Disorders, is actively recruiting participants, sponsored by Massachusetts General Hospital.

RECRUITING
Registry status
NA
Development phase
54 participants
Enrollment target
1
Study location

Study Summary

Cognitive Behavioral Therapy (CBT) is the treatment of choice for youth anxiety. However, up to 80% of youth with anxiety disorders do not access the services they need. Child CBT clinics nationwide have extremely long waits, on the order of 10-12 months. This leads to a vicious cycle, as children waiting for care experience worsening symptoms and decreased motivation, so that by the time they access care, their needs are more intensive and the treatment lasts longer and it takes longer for new children to be able to be assigned. Recently, single-session interventions (SSIs) have been developed that enable children to access CBT skills. The proposed randomized trial will evaluate the effects of a brief, web-based, self-guided SSI designed to reduce parent accommodation of children's anxiety, a parenting behavior that has been shown to maintain and worsen child anxiety. The main aim of the study is to examine whether the SSI reduces parent accommodation. As a secondary aim, the investigators will explore whether the SSI reduces children's anxiety symptoms over the first 6 months of CBT. The investigators will recruit parents of children who are on the waitlist to receive outpatient CBT. Results may suggest a promising approach to intervene with parents and children waiting to receive therapy.

Primary Outcome

The Pediatric Accommodation Scale is a parent-report of accommodation of their offspring's anxiety. Parents are asked to rate, on a 5-point scale from 0 (never) to 5 (always), the extent to which they accommodate their child's anxiety or avoidance behaviors. Total scores range from 0 to 25, with higher scores reflecting greater parental accommodation. Parents will report on their accommodation behaviors at baseline and 2-weeks follow-up.

Conditions Studied

Interventions

  • BEHAVIORAL The EMPOWER Program

Study Locations (1)

Massachusetts

  • Massachusetts General Hospital - Boston

Trial Details

FieldValue
Enrollment Target 54 participants
Start Date 2023-09-01
Est. Completion 2025-12-31
Phase NA
Massachusetts General Hospital

2,032 total trials

What NCT06043271 shows while recruiting

NCT06043271 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 54 participants, a relatively small participant target, below the 1,139-participant average among 84 other Anxiety Disorders trials with a reported enrollment target (95% lower).

The record links to 1 condition, with Anxiety Disorders appearing as the primary indexed condition, and to 1 intervention - of which The EMPOWER Program is the first listed.

NCT06043271 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT06043271 about?

NCT06043271 is a clinical study titled "A Single Session Parenting Intervention for Children on a Outpatient Therapy Waitlist". Cognitive Behavioral Therapy (CBT) is the treatment of choice for youth anxiety. However, up to 80% of youth with anxiety disorders do not access the services they need. Child CBT clinics nationwide have extremely long waits, on the order of 10-12 months. This leads to a vicious cycle, as children w...

What is the current status of trial NCT06043271?

This trial is currently recruiting. It is a NA study. The enrollment target is 54 participants. The study started on 2023-09-01. Estimated completion is 2025-12-31.

What conditions does trial NCT06043271 study?

This clinical trial studies the following conditions: Anxiety Disorders.

What interventions are being tested in trial NCT06043271?

The interventions under investigation include: The EMPOWER Program (BEHAVIORAL).

Who is sponsoring clinical trial NCT06043271?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06043271 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Anxiety Disorders

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06043271's enrollment target sits among peer trials

54 66th of 84 higher than 19 of 84 other Anxiety Disorders trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Anxiety Disorders trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01269853 · 54 participants · Phase 1

    Repeated Super-selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Relapsed GBM and AA

  • NCT02390752 · 54 participants · Phase 1

    Phase I Trial of TURALIO(R) (Pexidartinib, PLX3397) in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) and Tenosynovial Giant Cell Tumor ...

  • NCT02991248 · 54 participants · NA

    Improve Dynamic Lateral Balance of Humans With SCI

  • NCT02993900 · 54 participants · NA

    Image-Guided Gynecologic Brachytherapy

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06043271, the US trial registry maintained by the National Library of Medicine. NCT06043271 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.